2 results
Approved WMOCompleted
To determine if there is a difference in the pharmacokinetics of low-dose cisplatin with and without prehydration.
Approved WMORecruiting
Primary Objective1. To evaluate the efficacy of IMU-838 versus placebo as measured by quantitative magnetic resonance imaging (MRI) analysis for whole brain atrophy in progressive multiple sclerosis (PMS) patients with the Structural Imageā¦